Kestra Medical Technologies Ltd
KMTS27.520USD
-0.030-0.11%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
1.42BMarket Cap
LossP/E TTM
More Details of Kestra Medical Technologies Ltd Company
Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
Kestra Medical Technologies Ltd Info
Ticker SymbolKMTS
Company nameKestra Medical Technologies Ltd
IPO dateMar 06, 2025
CEOWebster (Brian Daniel)
Number of employees330
Security typeOrdinary Share
Fiscal year-endMar 06
Address3933 Lake Washington Blvd Ne
CityKIRKLAND
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code98033
Phone14252798002
Website
Ticker SymbolKMTS
IPO dateMar 06, 2025
CEOWebster (Brian Daniel)
Company Executives of Kestra Medical Technologies Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
309.34K
-22.19%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
104.92K
-13.17%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
--
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
14.84K
-59.79%
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
--
Mr. Phillip D. Foshee, Jr.
Mr. Phillip D. Foshee, Jr.
Senior Vice President - Research & Development
Senior Vice President - Research & Development
--
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--
Mr. Maxwell Bikoff
Mr. Maxwell Bikoff
Independent Director
Independent Director
--
--
Mr. Al Ford
Mr. Al Ford
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
309.34K
-22.19%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
104.92K
-13.17%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
--
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
14.84K
-59.79%
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
--
Mr. Phillip D. Foshee, Jr.
Mr. Phillip D. Foshee, Jr.
Senior Vice President - Research & Development
Senior Vice President - Research & Development
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Bain Capital Private Equity, LP
46.31%
Fidelity Management & Research Company LLC
7.45%
Endeavour Medtech Growth II LP
4.54%
Ally Bridge Group (HK) Limited
3.91%
T. Rowe Price Associates, Inc.
3.11%
Other
34.68%
Shareholders
Shareholders
Proportion
Bain Capital Private Equity, LP
46.31%
Fidelity Management & Research Company LLC
7.45%
Endeavour Medtech Growth II LP
4.54%
Ally Bridge Group (HK) Limited
3.91%
T. Rowe Price Associates, Inc.
3.11%
Other
34.68%
Shareholder Types
Shareholders
Proportion
Private Equity
46.31%
Investment Advisor
21.46%
Investment Advisor/Hedge Fund
11.85%
Corporation
4.54%
Venture Capital
2.82%
Hedge Fund
1.97%
Individual Investor
0.99%
Research Firm
0.20%
Bank and Trust
0.03%
Other
9.84%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
138
48.47M
94.21%
+1.86M
2025Q2
93
49.39M
96.22%
+48.70M
2025Q1
74
47.97M
93.41%
+47.97M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Bain Capital Private Equity, LP
27.02M
52.52%
--
--
Jun 30, 2025
Fidelity Management & Research Company LLC
2.84M
5.52%
+531.65K
+23.05%
Jun 30, 2025
Endeavour Medtech Growth II LP
2.65M
5.14%
+2.65M
--
Mar 31, 2025
Ally Bridge Group (HK) Limited
2.28M
4.44%
--
--
Jun 30, 2025
T. Rowe Price Associates, Inc.
990.60K
1.93%
+141.18K
+16.62%
Jun 30, 2025
Omega Fund Management, LLC
1.65M
3.2%
-150.00K
-8.35%
Jun 30, 2025
AllianceBernstein L.P.
1.31M
2.55%
+128.31K
+10.84%
Jun 30, 2025
Brown Advisory
580.02K
1.13%
+29.61K
+5.38%
Jun 30, 2025
Eventide Asset Management, LLC
1.06M
2.06%
+785.56K
+285.66%
Jun 30, 2025
Fidelity Institutional Asset Management
857.25K
1.67%
-35.40K
-3.97%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X HealthTech ETF
0.43%
Goldman Sachs Innovate Equity ETF
0.13%
Fidelity Blue Chip Growth ETF
0.06%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Global X Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Morningstar Small-Cap ETF
0.01%
View more
Global X HealthTech ETF
Proportion0.43%
Goldman Sachs Innovate Equity ETF
Proportion0.13%
Fidelity Blue Chip Growth ETF
Proportion0.06%
JPMorgan BetaBuilders US Small Cap Equity ETF
Proportion0.04%
iShares Russell 2000 Growth ETF
Proportion0.02%
Fidelity Nasdaq Composite Index ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
iShares Morningstar Small-Cap ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Kestra Medical Technologies Ltd?
The top five shareholders of Kestra Medical Technologies Ltd are:
Bain Capital Private Equity, LP holds 27.02M shares, accounting for 52.52% of the total shares.
Fidelity Management & Research Company LLC holds 2.84M shares, accounting for 5.52% of the total shares.
Endeavour Medtech Growth II LP holds 2.65M shares, accounting for 5.14% of the total shares.
Ally Bridge Group (HK) Limited holds 2.28M shares, accounting for 4.44% of the total shares.
T. Rowe Price Associates, Inc. holds 990.60K shares, accounting for 1.93% of the total shares.
Bain Capital Private Equity, LP holds 27.02M shares, accounting for 52.52% of the total shares.
Fidelity Management & Research Company LLC holds 2.84M shares, accounting for 5.52% of the total shares.
Endeavour Medtech Growth II LP holds 2.65M shares, accounting for 5.14% of the total shares.
Ally Bridge Group (HK) Limited holds 2.28M shares, accounting for 4.44% of the total shares.
T. Rowe Price Associates, Inc. holds 990.60K shares, accounting for 1.93% of the total shares.
What are the top three shareholder types of Kestra Medical Technologies Ltd?
The top three shareholder types of Kestra Medical Technologies Ltd are:
Bain Capital Private Equity, LP
Fidelity Management & Research Company LLC
Endeavour Medtech Growth II LP
Bain Capital Private Equity, LP
Fidelity Management & Research Company LLC
Endeavour Medtech Growth II LP
How many institutions hold shares of Kestra Medical Technologies Ltd (KMTS)?
As of 2025Q3, 138 institutions hold shares of Kestra Medical Technologies Ltd, with a combined market value of approximately 48.47M, accounting for 94.21% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -2.01%.
What is the biggest source of revenue for Kestra Medical Technologies Ltd?
In --, the -- business generated the highest revenue for Kestra Medical Technologies Ltd, amounting to -- and accounting for --% of total revenue.
